Peripheral blood biomarkers in systemic sclerosis -associated interstitial lung diseases
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 1
Abstract
Interstitial lung disease (ILD) can lead to significant morbidity and excess mortality in systemic sclerosis (SSc) patients. The early identification of patients at risk of progressive ILD is the main challenges for treating this highly variable disease. Although high resolution CT (HRCT), lung function tests (PFTs), bronchial lavage fluid (BALF), lung biopsy can be used to detect SSc-ILD, it is necessary to find reliable predictors for the disease progression. Peripheral blood biomarkers offer the advantages of being readily obtained, non-invasive, and serially monitored. New insights during the past several years have underscored the epithelial and endothelial cell injury with inflammatory and immune activation impacting of clinically significant SSc-associated ILD, but the pathogenesis of SSc-ILD is unknown. Some serum biomarkers including SP-D, KL-6, IL-9, MMPs, MCP-1, Defensins, IL-8 CXCL10 and CCL18 have identified to be associated with SSc-ILD. Future more cohorts, well-designed and long-term studies are needed to find more prospective biomarkers that influence SSc-ILD disease progression.
Authors and Affiliations
Ciyuan Yu, Shuli Song, Juan Chen
Keywords
Related Articles
- EP ID EP603812
- DOI -
- Views 71
- Downloads 0
Refractory thrombocytopenia in SLE patient with massive thigh hematoma and hematuria successfully treated with Rituximab: Case Report
Background: Systemic Lupus Erythematosus is a multisystemic inflammatory disease with broad clinical presentation, 9.5% to 44.5% of patients with SLE have thrombocytopenia complication of different grades. No significant...
Nanomedicine in rheumatology: A new field in the diagnosis and therapy of rheumatic diseases
Nanomedicine is a prolific and vastly expanding field of medicine rendering important new avenues to improve diagnosis and treatment of human maladies. However, safety of the nanomaterials and therapeutic agents must be...
Cardiovascular disease is associated with activity limitations in osteoarthritis patients
Background: To investigate the associations between Cardiovascular Disease (CVD) and Cardiovascular (CV) risk factors with activity limitations in patients with knee or hip Osteoarthritis (OA). Methods and Findings: Cons...
Piriformis syndrome: Still unsolved issues
Piriformis Syndrome (PS) is an example of extra-spinal sciatica due to compressive neuropathy and can also be named as ‘deep gluteal syndrome’, ‘pelvic outlet syndrome’ or ‘pseudo-sciatica’. Its prevalence among Low Back...
The correlation between blood lead levels and knee osteoarthritis: a preliminary Egyptian study
Background: Lead is a common ubiquitous environmental pollutant. The increasing prevalence of knee Osteoarthritis (OA) among young patients is suggestive of a possible contribution of environmental factors such as lead....